UPDATE | June 29, 2026

The future of global biopharma manufacturing networks

  • MAIL

Amid geopolitical uncertainty and evolving supply chain risks, biologics production is shifting from centralized models toward regional, resilient manufacturing networks. In this episode of Off Script, Samsung Biologics' Jeff Mason discusses how CDMOs are adapting, including the company's first U.S. facility acquisition in Rockville, Maryland. The conversation covers manufacturing redundancy, vertically integrated supply chains, and the future of global production ecosystems. 


Tune in to hear the full discussion.

Amid geopolitical uncertainty and evolving supply chain risks, biologics production is shifting from centralized models toward regional, resilient manufacturing networks. In this episode of Off Script, Samsung Biologics' Jeff Mason discusses how CDMOs are adapting, including the company's first U.S. facility acquisition in Rockville, Maryland. The conversation covers manufacturing redundancy, vertically integrated supply chains, and the future of global production ecosystems. 


Tune in to hear the full discussion.

Share article

  • MAIL

Related Content

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Interests
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required